U.S. markets open in 6 hours 35 minutes

ReShape Lifesciences Inc. (RSLS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8500-0.0600 (-2.06%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close2.9100
Open2.9000
Bid0.0000 x 1100
Ask0.0000 x 900
Day's Range2.8100 - 2.9499
52 Week Range0.7200 - 10.7700
Volume800,850
Avg. Volume4,153,261
Market Cap45.15M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-3.0190
Earnings DateNov 04, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ReShape Lifesciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/23/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • GlobeNewswire

    ReShape Lifesciences™ to Host Exhibit at Bariatric Summit

    ReShape Director of reshapecare™ Heather Mackie will be speaking at the conferenceSAN CLEMENTE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company will host an exhibit at the upcoming 17th Annual Bariatric Summit in Washington, D.C. September 18-19, 2021. ReShape Senior Director of reshapecare™ Heather Mackie, MS, RDN, LD will be presenting and participating in focal patient care

  • GlobeNewswire

    ReShape Lifesciences™ to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 2021

    SAN CLEMENTE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced that its leadership will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on Monday, September 20, 2021, at 2:05 p.m. ET. The Company’s presentation details include: Date: September 20, 2021Time: 2:05 p.m. ETLocation: Webcast Link An audio webcast of ReShape’s presentation will be avai

  • GlobeNewswire

    ReShape Lifesciences™ Appoints Al Diaz as Vice President of Operations and Research and Development

    SAN CLEMENTE, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the appointment of Al Diaz as Vice President of Operations and Research and Development. Mr. Diaz will be responsible for overseeing the company’s manufacturing operations and research and development efforts. “I am excited to join the executive team at ReShape Lifesciences™ and to lead multiple key programs and projects that wi